1 - 2 out of 2Page size: 10
  1. 2021

  2. Co-stimulatory versus cell death aspects of agonistic cd40 monoclonal antibody selicrelumab in chronic lymphocytic leukemia

    Delgado, R., Kielbassa, K., ter Burg, J., Klein, C., Trumpfheller, C., de Heer, K., Kater, A. P. & Eldering, E., 2 Jun 2021, In: Cancers. 13, 12, 3084.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2020

  4. Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

    Haselager, M. V., Kielbassa, K., ter Burg, J., Bax, D. J. C., Fernandes, S. M., Borst, J., Tam, C., Forconi, F., Chiodin, G., Brown, J. R., Dubois, J., Kater, A. P. & Eldering, E., 17 Dec 2020, In: Blood. 136, 25, p. 2918-2926 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 5949362